Below are the most recent publications written about "GTP Phosphohydrolases" by people in Profiles.
-
Brose MS, Schlumbeger M, Jeffers M, Kappeler C, Meinhardt G, Pe?a CEA. Analysis of Biomarkers and Association With Clinical Outcomes in Patients With Differentiated Thyroid Cancer: Subanalysis of the Sorafenib Phase III DECISION Trial. Clin Cancer Res. 2019 12 15; 25(24):7370-7380.
-
Lasota J, Kowalik A, Felisiak-Golabek A, Zieba S, Waloszczyk P, Masiuk M, Wejman J, Szumilo J, Miettinen M. Primary malignant melanoma of esophagus: clinicopathologic characterization of 20 cases including molecular genetic profiling of 15 tumors. Mod Pathol. 2019 07; 32(7):957-966.
-
Dankwa L, Richardson J, Motley WW, Scavina M, Courel S, Bardakjian T, Z?chner S, Scherer SS. A novel MFN2 mutation causes variable clinical severity in a multi-generational CMT2 family. Neuromuscul Disord. 2019 02; 29(2):134-137.
-
Felisiak-Golabek A, Inaguma S, Kowalik A, Wasag B, Wang ZF, Zieba S, Pieciak L, Rys J, Kopczynski J, Sarlomo-Rikala M, G?zdz S, Lasota J, Miettinen M. SP174 Antibody Lacks Specificity for NRAS Q61R and Cross-Reacts With HRAS and KRAS Q61R Mutant Proteins in Malignant Melanoma. Appl Immunohistochem Mol Morphol. 2018 Jan; 26(1):40-45.
-
Wesolowski J, Weber MM, Nawrotek A, Dooley CA, Calderon M, St Croix CM, Hackstadt T, Cherfils J, Paumet F. Chlamydia Hijacks ARF GTPases To Coordinate Microtubule Posttranslational Modifications and Golgi Complex Positioning. MBio. 2017 05 02; 8(3).
-
Lasota J, Kowalik A, Felisiak-Golabek A, Inaguma S, Wang ZF, Pieciak L, Zieba S, Peksa R, Kopczynski J, Okon K, Waloszczyk P, Gozdz S, Biernat W, Miettinen M. SP174, NRAS Q61R Mutant-Specific Antibody, Cross-Reacts With KRAS Q61R Mutant Protein in Colorectal Carcinoma. Arch Pathol Lab Med. 2017 Apr; 141(4):564-568.
-
Witt RL. Targeted Next Generation Sequencing with ThyroSeq v2.1 for Indeterminate Thyroid Nodules in Clinical Practice. Del Med J. 2016 Dec; 88(12):366-372.
-
Miles WO, Lembo A, Volorio A, Brachtel E, Tian B, Sgroi D, Provero P, Dyson N. Alternative Polyadenylation in Triple-Negative Breast Tumors Allows NRAS and c-JUN to Bypass PUMILIO Posttranscriptional Regulation. Cancer Res. 2016 12 15; 76(24):7231-7241.
-
Song N, Pogue-Geile KL, Gavin PG, Yothers G, Kim SR, Johnson NL, Lipchik C, Allegra CJ, Petrelli NJ, O'Connell MJ, Wolmark N, Paik S. Clinical Outcome From Oxaliplatin Treatment in Stage II/III Colon Cancer According to Intrinsic Subtypes: Secondary Analysis of NSABP C-07/NRG Oncology Randomized Clinical Trial. JAMA Oncol. 2016 Sep 01; 2(9):1162-9.
-
Weber MM, Faris R, van Schaik EJ, McLachlan JT, Wright WU, Tellez A, Roman VA, Rowin K, Case ED, Luo ZQ, Samuel JE. The Type IV Secretion System Effector Protein CirA Stimulates the GTPase Activity of RhoA and Is Required for Virulence in a Mouse Model of Coxiella burnetii Infection. Infect Immun. 2016 09; 84(9):2524-33.